103 related articles for article (PubMed ID: 15635870)
1. [Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)].
Stejskal D; Zurek M; Svecová R; Zapletalová J; Bartek J; Oral I; Horalík D; Lacnák B; Jedelský L; Lenobelová H
Vnitr Lek; 2001 Jan; 47(1):60-2. PubMed ID: 15635870
[No Abstract] [Full Text] [Related]
2. [Tartrate resistant acid phosphatase].
Yoh K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():349-53. PubMed ID: 15035150
[No Abstract] [Full Text] [Related]
3. [Tartrate resistant acid phosphatase].
Yoh K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
[No Abstract] [Full Text] [Related]
4. [Metabolic markers of bone and clinical use].
Miki T; Naka H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():221-6. PubMed ID: 18161110
[No Abstract] [Full Text] [Related]
5. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
[No Abstract] [Full Text] [Related]
6. [New approved markers of bone turnover for osteoporosis in Japan].
Miki T; Masaki H
Clin Calcium; 2012 Jun; 22(6):877-83. PubMed ID: 22653028
[TBL] [Abstract][Full Text] [Related]
7. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
8. Suitability of tartrate-resistant acid phosphatase type 5b as a screening marker for bone mineral density in community-dwelling elderly individuals.
Irie S; Hayashida N; Shinkawa T; Taira Y; Sekitani Y; Teraoka S; Hashiguchi K; Yoshida K; Morishita M; Takamura N
Tohoku J Exp Med; 2011 Jun; 224(2):105-10. PubMed ID: 21597244
[TBL] [Abstract][Full Text] [Related]
9. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
10. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
11. [Effects of SERMs on bone health. SERM and metabolic markers of bone].
Takami M; Shimada H
Clin Calcium; 2010 Mar; 20(3):365-71. PubMed ID: 20190366
[TBL] [Abstract][Full Text] [Related]
12. [Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
Suzuki A
Clin Calcium; 2011 Sep; 21(9):1393-6. PubMed ID: 21881203
[TBL] [Abstract][Full Text] [Related]
13. Reference intervals for two bone-derived enzyme activities in serum: bone isoenzyme of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TR-ACP).
Panteghini M; Pagani F
Clin Chem; 1989 Jan; 35(1):180-1. PubMed ID: 2910567
[No Abstract] [Full Text] [Related]
14. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
16. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
[TBL] [Abstract][Full Text] [Related]
18. [Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker].
Okuno S; Inaba M
Clin Calcium; 2009 Aug; 19(8):1084-91. PubMed ID: 19638691
[TBL] [Abstract][Full Text] [Related]
19. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
20. [The measurements of bone turnover].
Kushida K; Takahashi M; Hoshino H
Nihon Rinsho; 1997 Mar; 55 Suppl 1():295-8. PubMed ID: 9097608
[No Abstract] [Full Text] [Related]
[Next] [New Search]